Clinical Trials Logo

Filter by:
NCT ID: NCT00958841 Completed - Pancreatic Neoplasm Clinical Trials

Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin

Start date: September 2009
Phase: Phase 2
Study type: Interventional

This study will assess the effectiveness and safety of pasireotide long-acting release in patients who have rare tumors of neuroendocrine origin.

NCT ID: NCT00958100 Completed - HIV Infections Clinical Trials

Raltegravir Switch for Toxicity or Adverse Events

RaSTA
Start date: August 2009
Phase: Phase 2
Study type: Interventional

This study aims to verify the persistent control of the virus replication at 48 weeks after the simplification to tenofovir + emtricitabine + raltegravir or to lamivudine+abacavir+raltegravir in patients with optimal virological suppression without any virological failure to previous combined antiretroviral therapies needing a therapeutic switch for toxicity related issues or adverse events.

NCT ID: NCT00956917 Completed - Clinical trials for Body Composition Measurement

Comparison Study for Bioelectrical Impedance Device to Measure Human Body Composition

Start date: May 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if the ElectroFluidGraph(tm) (EFG) impedance analyzer is comparable to a predicate device in measuring human body composition.

NCT ID: NCT00956761 Completed - Seasonal Influenza Clinical Trials

Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted With MF59C.1, Seasonal Influenza Vaccine, Formulation 2009-2010

Start date: June 2009
Phase: Phase 2
Study type: Interventional

This is a trial for annual registration of the updated seasonal influenza vaccine formulation.

NCT ID: NCT00955357 Completed - Partial Epilepsies Clinical Trials

Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures

Start date: August 2009
Phase: Phase 4
Study type: Interventional

To evaluate the efficacy and safety of oral Lacosamide as first add on treatment in subjects with uncontrolled partial-onset seizures after prior treatment with a monotherapy Antiepileptic Drug (AED) regimen compared to subjects who have received treatment with at least 2 AEDs.

NCT ID: NCT00954447 Completed - Clinical trials for Diabetes Mellitus, Type 2

Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With Type 2 Diabetes

Start date: August 2009
Phase: Phase 3
Study type: Interventional

The objective of the current study is to investigate the efficacy, safety and tolerability of linagliptin (5 mg / once daily) compared to Placebo during long term treatment (52 weeks and longer) in combination with basal insulin in patients with type 2 diabetes mellitus with insufficient glycaemic control.

NCT ID: NCT00954395 Completed - Clinical trials for Venous Thromboembolism

DULCIS (D-dimer and ULtrasonography in Combination Italian Study)

DULCIS
Start date: September 2008
Phase:
Study type: Observational

The purpose of this study is to evaluate the efficacy and safety of a standardized procedure to establish the optimal duration of anticoagulation in patients with venous thromboembolism.

NCT ID: NCT00953758 Completed - Clinical trials for Hematologic Malignancies

A Study Of PF-04449913 In Select Hematologic Malignancies

Start date: March 3, 2010
Phase: Phase 1
Study type: Interventional

This study examines the effect of a small molecule inhibitor to the Sonic Hedgehog pathway on select hematologic malignancies.

NCT ID: NCT00953394 Completed - Clinical trials for Neuroendocrine Tumors

5FU and Octreotide Long-acting Release (LAR) for Neuroendocrine Tumors

Start date: February 2002
Phase: Phase 2
Study type: Interventional

Well differentiated neuroendocrine carcinomas have low proliferative activity and conventional chemotherapy is not recommended. Metronomic chemotherapy, i.e. the frequent administration of cytotoxic drugs at low doses, has demonstrated antiangiogenetic properties. Since well differentiated NE carcinomas are highly vascular, there is a rationale for testing metronomic chemotherapy in this clinical setting. A phase II study was designed to test the activity of protracted 5-fluorouracil (5FU) infusion plus long-acting release (LAR) octreotide for patients with neuroendocrine carcinoma.

NCT ID: NCT00953355 Completed - Clinical trials for Polycystic Ovary Syndrome

Metformin and Folate Supplementation in Polycystic Ovary Syndrome (PCOS) Patients

Start date: January 2004
Phase: Phase 4
Study type: Interventional

Context: Metformin administration in women with polycystic ovary syndrome (PCOS) improves hormonal and metabolic patterns with beneficial effects in terms of reproductive outcomes and intermediate cardiovascular disease risk factors. Furthermore, reduced folate and vitamin B12, and increased homocysteine (Hcy) levels have been found in type-2 diabetes mellitus patients treated with metformin. Objective: To evaluate if metformin administration exerts any effects on Hcy levels, and if folate supplementation may improve endothelial structure and function in PCOS patients.